Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $171.66M.
ENTERPRISE VALUE (EV)
$171.66M
AN2 Therapeutics, Inc.
Market Cap
$191.61M
Enterprise Value (EV)
$171.66M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | $191.61M | $171.66M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $195.29M | $188.95M |
| Journey Medical Corporation (DERM)vs › | $182.88M | $182.78M |
| Electra Therapeutics Inc. (ETRA)vs › | $202.05M | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.31M | $142.07M |
| Cue Biopharma, Inc. (CUE)vs › | $178.56M | $169.97M |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.22M | $151.40M |
| Precision BioSciences, Inc. (DTIL)vs › | $173.89M | $115.91M |
| MediWound Ltd. (MDWD)vs › | $172.65M | $177.84M |
| Alector, Inc. (ALEC)vs › | $213.17M | $186.01M |
Market Cap
$191.61M
Total Debt
$0.00
Cash
$19.94M
Enterprise Value
$171.66M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
